Biotech Fund Flanders

Europe, Antwerpen, Belgium, Antwerp

Description

Based in Belgium, Biotech Fund Flanders is a venture capital firm focused on emerging biotechnology companies.

Investor Profile

Biotech Fund Flanders has made 9 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

Series B (44%)
Series C (22%)
Series D (11%)
Series Unknown (11%)
Private Equity (11%)

Country Focus

Belgium (78%)
France (11%)
Togo (11%)

Industry Focus

Biotechnology
Pharmaceutical
Biopharma
Health Care
Health Diagnostics
Clinical Trials
Medical
Therapeutics
Veterinary
Mobile Apps

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biotech Fund Flanders frequently co-invest with?

Abingworth

Europe, England, United Kingdom, London

Co-Investments: 3

Gimv

Europe, Antwerpen, Belgium, Antwerpen

Co-Investments: 8

Ventech

Europe, Ile-de-France, France, Paris

Co-Investments: 2

VIB

Europe, Oost-Vlaanderen, Belgium, Gent

Co-Investments: 3

Johnson & Johnson Development Corporation

North America, New Jersey, United States, New Brunswick

Co-Investments: 2

Aescap Venture

Europe, Noord-Holland, The Netherlands, Amsterdam

Co-Investments: 2

KBC

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels

Co-Investments: 3

EQT Life Sciences

Europe, Noord-Holland, The Netherlands, Amsterdam

Co-Investments: 5

Sofinnova Partners

Europe, Ile-de-France, France, Paris

Co-Investments: 3

Baekeland Funds

Europe, Gelderland, The Netherlands, Gent

Co-Investments: 3

What are some of recent deals done by Biotech Fund Flanders?

Virovet

Leuven, Vlaams-Brabant, Belgium

ViroVet is a pioneering company.

BiotechnologyPharmaceuticalVeterinary

Series BMay 28, 2020

Amount Raised: $6,647,249

Pronota

Ghent, Oost-Vlaanderen, Belgium

Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.

BiotechnologyHealth CareHealth Diagnostics

Series CJan 20, 2012

Amount Raised: $4,784,615

Pronota

Ghent, Oost-Vlaanderen, Belgium

Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.

BiotechnologyHealth CareHealth Diagnostics

Series BJun 29, 2009

Amount Raised: $7,360,000

ActoGeniX

Zwijnaarde, Oost-Vlaanderen, Belgium

A biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs.

BiopharmaBiotechnologyClinical TrialsPharmaceutical

Private EquityFeb 11, 2009

Amount Raised: $17,424,773

Diatos

Paris, Ile-de-France, France

Diatos is a biopharmaceutical company developing innovative therapies for unmet medical needs in cancer.

BiotechnologyMedicalTherapeutics

Series DJul 3, 2007

Amount Raised: $12,800,000

ActoGeniX

Zwijnaarde, Oost-Vlaanderen, Belgium

A biopharmaceutical company, focused on the development and commercialization of a new generation of biological drugs.

BiopharmaBiotechnologyClinical TrialsPharmaceutical

Series UnknownSep 19, 2006

Amount Raised: $25,351,145

Ablynx

Zwijnaarde, Oost-Vlaanderen, Belgium

Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.

BiopharmaBiotechnologyPharmaceutical

Series CAug 23, 2006

Amount Raised: $50,000,000

Ablynx

Zwijnaarde, Oost-Vlaanderen, Belgium

Ablynx is a biopharmaceutical company engaged in the discovery and development of nanobodies.

BiopharmaBiotechnologyPharmaceutical

Series BApr 6, 2004

Amount Raised: $30,000,000

Devgen

Lomé, Maritime, Togo

Devgen is a developer of hybrid rice seeds that protect crops from damage by pests.

Mobile Apps

Series BOct 1, 1999

Amount Raised: $24,675,332

Biotech Fund Flanders

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Biotech Fund Flanders frequently co-invest with?

What are some of recent deals done by Biotech Fund Flanders?

Ready to Raise Capital?

Pages

Free tools